Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Former Bristol Myers Squibb campus set up for ‘reshoring’
by Rick Mullin
June 26, 2020
| A version of this story appeared in
Volume 98, Issue 25
A former Bristol Myers Squibb facility near Princeton, New Jersey, has been acquired by Lincoln Equities Group and H.I.G. Realty Partners. The real estate firms intend to market the 111,000 m2 manufacturing and research campus to drug and biotech firms seeking to establish US manufacturing of drugs and drug chemicals that are currently outsourced. The campus includes nine production, lab, and storage buildings. PTC Therapeutics operates a biologics production facility and research labs at the site.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter